2011-1 Full Printed Journal

Abstract

Keywords

• -

2011-1 Tüm Dergi

Abstract

A Rare Etiology of Acute Abdomen Syndrome: Perforation of The Small Intestinal Lymphoma Akut Batın Sendromunun Nadir Bir Etyolojisi: İnce Barsak Lenfoma Perforasyonu Fatih Altıntoprak, Enis Dikicier, Yusuf Yürümez, Osman Nuri Dilek

Keywords

• -

References

1. Aoki K, Esaki S, Honda Y, Tos M. Effect of middle ear in- fection on pneumatization and growth of the mastoid process: an experimental study in pigs. Acta Otolaryngol. 1990;110:399-409.
2. Esaki S., Kikuchi Y., Aoki K, Honda YA. Study in children on the inhibited pneumatization of the mastoid in otitis media with effusion. Auris Nasus Larynx (Suppl 1). 1985;12:161- 162.
3. Nankano Y, Sato Y. Prognosis of the otitis media with effu- sion in children and size of the mastoid air cell system. Acta Otolaryngol (Stockh) (Suppl). 1990;471:56-61.
4. Diamant M. Otitis and pneumatization of the mastoid bone. Acta Otolaryngol (Stockh). 1940;60:11-14.
5. Schwartz M. Das Cholesteatom im Gehörgang und im Mit- telohr. Pathogenese, Diagnose, Therapie Thime, Stutgart 1966. S:795-796.
6. Tos M., Stangerup SE. The causes of asymmetry of the mastoid air cell system. Acta Otolaryngol (Stockh). 1985;99: 564-570.
7. Hug JE. A planimetric study of temporal bone pneumatizati- on. Acta Otolaryngol 1986;243:304-308.
8. Diamant M., Rubensohn C., Walender A. Otosalpingitis and mastoid pneumatization. Acta Otolaryngol (Stockh). 1958;49:381-388.

9. Lindeman P.,Shea JJ. Size of the mastoid air cell system
10. Mastoid Pnömatizasyonda Genetik Geçişin
11. in children with middle ear effusion. Laryngoscope 1980;90:1840-1844.
12. Tos M. Mannuel of the middle ear surgery Vol.2:Mastoid surgery and reconstructive procedures. Thieme Medical Publishers, Inc. New York, 1995:50-61.
13. Ikarashi H, Nakano Y. The effect of chronic middle ear inf- lamation on the pneumatization the tympanic bulla in pigs. Acta Otolaryngol (Stockh). 1987; 104: 130-137.
14. Sade J., Hadas. Prognostic evaluation of secretory otitis me- dia as a function of mastoidal pneumatization. Acta Otolary- ngol 1979;225:39-44.
15. Cheatle AH: The etiology and prevention of chronic middle ear suppuration. Acta Otolaryngol. 1923;5:283-285.
16. Ueda T., Eguchi S. Distribution of pneumatization of the tem- poral bone in chronic otitis media seen during age of antibi- otic therapy. J Otol Rhinol Laryngol (Japan). 1962;64:1539- 1542.
17. Witmaack K. Über die normale und die pathologische Pne- umatisation des Schlafenbeines einschliesslich ihrer Bezie- hungen zu der Mittelohrenkrankungen Jena: Gustav Fish- cher, 1918. 345-351.
18. Tumarkin A. On the and significance of hypocellularity of the mastoid. J Laryngol Otol, 1959;73:33-44.
19. Tos M., Stangerup SE. Mastoid pneumatization in secretory otitis: futher support for the environmental theory. Acta Oto- laryngol. 1984;98:110-118.
20. Tos M., Stangerup SE., Hivid G. Mastoid pneumatization: Evidance of the Environmental Theory. Arch Otolaryngol. 1984;110:502-507.
21. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993;128:586-90.
22. Carroll JK, Herrick B, Gipson T, Lee SP. Acute pancreatitis: diagnosis, prognosis, and treatment. Am Fam Physician 2007;75:1513-20.
23. Al- Bahrani AZ, Ammori BJ. Clinical laboratory assessment of acute pancreatitis. Clinica Chimica Acta 2005; 362:26-48.
24. Byrne MF, Mitchell RM, Stiffler H, Jowell PS, Branch MS, Pappas TN, et al. Extensive investigation of patients with mild elevations of serum amylase and/or lipase is “low yield”. Can J Gastroenterol
25. Sekimoto M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:10-24.
26. Kimura Y, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN Guidelenes for managemet pancreatitis: epidemiology, etyologi natural history,and outcome predictors in acute Pancreatitis. Hepatobiliary Pancreat Surg 2006;13:10-24.
27. Larvin M.. Assessment of severity and prognosis in acute pancreatitis. Eur J Gastroenterol Hepatol. 1997;9:122-30.
28. Beaux Ac, Palmer KR, Carter DC. Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 1995;37:121-126.
29. Yousaf M, McCallion K, Diamond T. Management of severe acute pancreatitis. Br J Surg. 2003; 90: 407-20.
30. Yokoi H, Naganuma T, Higashiguchi T. Prospektive study of protocol for selection treatment of acute pancreatitis based on scaring severity. Digestion 1999; 60: 14-18.
31. Mitchell RM, Byrne MF, Baillie J. Pancreatitis.Lancet 2003; 361: 1447-55.
32. Koizumi M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN Guidelines for the management of acute pancreatitis: diagnostic criteria for acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006; 13:25-32.
33. Vissers RJ, Abu-Laban RB. Acute and chronic pancreatitis. In: Tintinalli JE, Kelen GD, Stapczynski JS (eds.), Emergency medicine. A comprehensive study guide. 5th edition, New York: McGraw-Hill, 2000: 588-592.
34. Sargent S. Pathophysiology, diagnosis and management of acute pancreatitis. Br J Nurs. 2006; 15: 999-1005.
35. Tran DD, Cuesta MA. Evaluation of severity in paitents with acute pancreatitis.Am J Gastroenterol 1992;87:604-608.
36. Ertekin C, Kemertaş K, Günay K. Akut Pankreatit Ulusal Travma Dergisi 1995; 1: 14-21.
37. DiMagno MJ, DiMagno EP. New advances in acute pancreatitis. Curr Opin Gastroenterol. 2007;23:494-501.
38. Vissers RJ, Abu-Laban RB. Acute and chronic pancreatitis. In: Tintinalli JE, Kelen GD, Stapczynski JS (eds.), Emergency medicine. A comprehensive study guide. 5th edition, New York: McGraw-Hill, 2000: pp.588-592.
39. Alhajeri A, Erwin S. Acute pancreatitis: value and impact of CT severity index. Abdom Imaging. 2008; 33: 18-20.
40. Ayten R, Cetinkaya Z, Yenicerioğlu A. Akut Pankreatitli Olgularımızın Retrospektif Değerlendirilmesi. F.U. Sağ. Bil. Derg. 2007:21:133- 136.
41. Hirota M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN Guidelines for the management of acute pancreatitis: severity assessment of acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13: 33- 41.
42. Bollen TL, van Santvoort HC, Besselink MG, van Leeuwen MS, Horvath KD, Freeny PC, et al. Dutch Acute Pancreatitis Study Group. The Atlanta Classification of acute pancreatitis revisited. Br J Surg. 2008;95: 6-21.
43. Taşkın B, Nazlı O, Çökmez A, Özdemir D, Başaran A, Deniz S Akut Pankreatit Olgularının Değerlendirilmesi Klinik ve Deneysel Cerrahi Dergisi 1995;3:235.
44. Vriens PW, Linde P, Solotema ET, Warmerdam PE, Breslau PJ. Computed tomography severity index is an early prognostic tool for acute pancreatitis. J Am Coll Surg 2005; 201:497-502.
45. Wyncoll DL. The management of severe acute necrotising pancreatitis: an evidence-based review of the literature. Intensive Care Med 1999;25:146-56.
46. McMahon MJ, Playforth MJ, Pickford IR. A comparative study of methods for the prediction of severity of acute pancreatitis. Br J Surg 1980;67:22-5.
47. Elmas N. The role of diagnostic radiology in pancreatitis. European Journal of Radiology 2001; 38: 120-132.
48. Kim YS, Lee BS, Kim SH, Seong JK, Jeong HY, Lee HY. Is there correlation between pancreatic enzyme and radiological severity in acute pancreatitis? World J Gastroenterol. 2008;14:2401-5.
49. Yaşar M, Aydın M, Aslaner A, Güler O. Ultrasonografının ERCP ye göre koledok taşlarının tanısındaki yeri Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 2007;40:1-3.
50. Kaw M, Al-Antably Y, Kaw P. Management of gallstone pancreatitis: cholecystectomy or ERCP and endoscopic sphincterotomy. Gastrointestinal Endoscopy 2002; 56: 61.
51. Mıstık R. Türkiye’de viral hepatit Epidemiyolojisi yayınların irdelenmesi. Tabak F, Balık İ, Tekeli E (eds). Viral Hepatit’2007. Viral Hepatitle Savaşım Derneği, İstanbul 2006;10:51.
52. Mıstık R, Balık İ. Türkiye’de viral hepatitlerin epidemiyolojisi: bir metaanaliz. K.Kılıçturgay (ed):Viral Hepatit ‘98, Viral Hepatitle Savaşım Derneği, İstanbul, 1998;10-40.
53. Bilgin N, Simsek H, Haberal M. Prevalance of anti-HCV positivity in hemodialysis and renal transplant patients at our center. Transplant Proc. 1993;25:3261-3262.
54. World Health Organization. Blood Transfusion Safety Team of the Department of Blood Safety and Clinical Technology 1-6, WHO, Geneva. 2001. WHO/BTS/01.1. www.who.int/bct
55. Ulutürk R. Kan donörlerinde yapılan rutin tarama testlerinin 11 yıllık değerlendirilmesi. Türk Mikrobiyol Cem. Derg. 2010;40:41-47.
56. Özdemir D, Kurt H. Hepatit B Virusu Enfeksiyonlarının Epidemiyolojisi. Tabak F, Balık İ, Tekeli E (eds). Viral Hepatit’2007. Viral Hepatitle Savaşım Derneği, İstanbul, 2006;108.
57. Arabacı F, Şahin HA, Şahin İ, Kartal Ş. Kan donörlerinde HBV, HCV, HIV ve VDRL seropozitifliği. KLİMİK Dergisi. 2003;16:18-20.
58. Gül M, Çıragil P, Aral M, Doğramacı N. Kan donörlerinin gönüllü olma durumları ile HBV, HCV, HIV ve Sifiliz tarama test sonuçlarının değerlendirilmesi. KLİMİK 2005 XII. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi, Mikrobiyoloji ve Klinik Mikrobiyoloji Ana Bilim Dalı, Kahramanmaraş. 317.
59. Kader Ç, Erbay A, Birengel S, Gürbüz M. Kan donörlerinde Hepatit B Virusu, Hepatit C Virusu, İnsan İmmün Yetmezlik Virusu İnfeksiyonu ve Sifilis Seroprevalansı. KLİMİK Dergisi. 2010; 23: 95-99.
60. Taşlı Ö. Türkiye’de kan bankacılığının yeniden yapılanmasında Türk Kızılayı’nın rolü.[İnternet]. İstanbul: Kan Merkezleri ve Transfüzyon Derneği [erişim 21 Haziran 2010]. http://www.kmtd. org.tr/pdf/ omer_tasli.pdf.
61. Sünbül M. HCV Enfeksiyonunun Epidemiyolojisi ve Korunma. Tabak F, Balık İ, Tekeli E (eds). Viral Hepatit’2007. Viral Hepatitle Savaşım Derneği, İstanbul, 2006;209.
62. Yılmaz G, Özkan E. Retroviruslar. Topçu A, Söyletir G, Doğanay M (eds). Infeksiyon Hastalıkları ve Mikrobiyolojisi. Nobel Tıp Kitabevleri. 2002;1334-1335.
63. Bal E. Türkiye’de HIV/AIDS epidemiyolojisi. HIV/AIDS Sempozyum Sunumları (3-4 Aralık 2009, Ankara) [İnternet]. Ankara: Hacettepe Üniversitesi HIV/AIDS Tedavi ve Araştırma Merkezi erişim 21 Haziran 2010]. http://www.hatam.hacettepe.edu.tr /sunum1209/3aralik/2_ files/frame.htm
64. Temiz H, Gül K. Kan vericilerinin HBsAg, anti-HCV, anti-HIV ve VDRL test sonuçlarının değerlendirilmesi. İnfeksiyon Derg. 2008;22:79-82.
65. Kaya S. Kan donörlerinde hepatit B virusu, hepatit C virusu ve insan immun yetmezlik virusu infeksiyonu ve sifilis sıklığı. KLİMİK Derg. 2008;21:65-8.
66. Sümer Z, Sümer H, Bakıcı MZ, Koç S. Cumhuriyet Üniversitesi Tıp Fakültesi Kan Merkezi donör kanlarının HBsAg, anti-HCV, anti-HIV ve sifilis seropozitifliği yönünden değerlendirilmesi. Viral Hepatit Derg. 2001;7:330-332.
67. Aydın F, Çubukçu K, Yetişkul S, Yazıcı Y, Kallıkkaya N. Trabzon Farabi Hastanesi kan donörlerinde HBsAg, anti-HCV, anti-HIV ve sifilis reaginik antikor seropozifliğinin retrospektif olarak değerlendirilmesi. Mikrobiyol Bült. 2002;36:85-90.
68. Uyanık MH, Kuzucu Malçok H, Aktaş O. Kan donörlerinde hepatit B, hepatit C ve HIV-1/2 seroprevalansı. Atatük Üniv Tıp Derg. 2004;36:35-38.
69. Mutlu B, Meriç M, Willke A. Kan donölerinde hepatit B ve C virusu, İnsan immun yetmezlik virusu ve sifilis seroprevalansı. Mikrobiyol Bült. 2004;38:445-448.
70. Dilek İ, Demir C, Bay A, Akdeniz H, Öner AF. Seropositivity rates of HBsAg, anti-HCV, anti-HIV and VDRL in blood donors in Eastern Turkey. Turk J Hematol. 2007;24:4-7.
71. Ağuş N, Özkalay Yılmaz N, Cengiz A, Şanal E, Sert H. Kan donörlerinde HBsAg, anti-HCV ve anti-HIV1/2 seroprevelansı. ANKEM Derg. 2008; 22:7-9.
72. Öksüz Ş, Yıldırım M, Özaydın Ç, Şahin İ, Şencan İ. Düzce bölgesi kan vericilerinde HBsAg, anti-HCV ve anti-HIV seroprevalansı. Viral Hepatit Derg. 2008;13:27-30.
73. Uzun C. Kan donörlerinde HBsAg, anti-HCV, anti-HIV ve RPR sonuçlarının değerlendirilmesi. Türk Mikrobiyol. Cem. Derg.
74. Kaya S, Alanoğlu G, Polat M, Sipahi T. Süleyman Demirel Üniversitesi Kan Merkezi’nin 2000-2007 yılları tarama test sonuçları. Süleyman Demirel Üniv Tıp Fak Derg. 2009;16:13-15.
75. Ankara: Viral Hepatitle Savaşım Derneği, 2007:10-50
76. Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, et al. L. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol. 1997;92:1298- 1301.
77. Atanasiu V, Manolescu B, Stoian I. Hepcidin-central regulator of iron metabolism. Eur J Haematol. 2007;78:1-10.
78. Hershko C, Peto TE. Non-transferrin plasma iron. Br J Haematol. 1987;66:149-51.
79. Hershko C. Mechanism of iron toxicity and its possible role in red cell membrane damage. Sem Hematol. 1989;26:277-285.
80. Lok ASF, Mcmahon BJ. AASLD practise guidlines. Hepatology. 2009;50:1-36.
81. Ishak KG, Baptista A, Bianchi L. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
82. MacSween RNM, Burt AD, Portman BC, Ihsak KG, Scheuer PJ, Anthony PP. Pathology of the Liver. 4th ed. London: Churchill Livingstone, 2002.
83. Lo Re III V, Kostman JR. Management of chronic hepatitis C. Postgrad Med J. 2005;81:376-82.
84. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 1992;102:2108-2113.
85. Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol. 2004;99:286-291.
86. Tsung-Jung L, Li-Ying L, Shyr-Yi L, Chih-Lin L, Ting-An C. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C. World J Gastroenterol. 2006;12:4897-4901
87. D’souza RFC, Feakıns R, Mears L, Sabın CA, FosterGR. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2005;21:519-524.
88. Arora S, O’Brian C, Zeuzem S. Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40KD) plus ribavirin: impact on health-related quality of life. J Gastroenterol Hepatol. 2006;21:406-12.
89. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology. 1997;25:759-768. Tıp Dergisi 2005;20:244-245.
90. Albayrak D, İbis AC, Hatipoglu AR, Polat N, Hoscoskun Z. Perfore primer ince barsak lenfoması: Olgu sunumu. Trakya Univ Tıp Fak Derg 2008;25:60-4.